Drugs / Dendritic Cells Vaccine
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT01483274 | Mar → Jun 2015 | acute myeloid leukemia | University of Louisville | Withdrawn | No outcome recorded |
| Phase 1 | NCT01803152 | Jan 2014 → Sep 2019 | bone sarcoma, soft tissue sarcoma | Macarena De La Fuente, MD | Completed | No outcome recorded |
| Phase 1 | NCT04002804 | Apr 2010 → Oct 2011 | glioblastoma | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04801147 | Jun 2010 → Dec 2023 | glioblastoma | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01348256 | Nov 2010 → Dec 2018 | colorectal carcinoma, metastasis from malignant tumor of colon | Clinica Universidad de Navarra, Universidad de Navarra | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cells Vaccine | “Dendritic cells vaccine” NCT01483274 ↗ |
| Action | Deplete | “to kill all (residual) tumour cells which infiltrate in the adjacent areas of the brain” NCT04801147 ↗ |
| Modality | Vaccine | “Dendritic cell vaccines loaded with autologous tumor lysates were tested” PMID 30268156 ↗ Sep 2018 |
| Route | Other | “Vaccine doses will be injected in the forearm of the patient.” NCT04002804 ↗ |